Competition (‘Steal’ Phenomenon) between [(68)Ga]Ga-PSMA-11 Uptake in Prostate Tumor Tissue Versus Healthy Tissue

por van der Sar, Esmée C. A., de Keizer, Bart, Lam, Marnix G. E. H., Braat, Arthur J. A. T.
Publicado 2021

Baseline Imaging Derived Predictive Factors of Response Following [(177)Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Bas...

por van der Sar, Esmée C. A., Kühr, Adinda J. S., Ebbers, Sander C., Henderson, Andrew M., de Keizer, Bart, Lam, Marnix G. E. H., Braat, Arthur J. A. T.
Publicado 2022

Cost-effectiveness of the implementation of [(68)Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging

por van der Sar, Esmée C. A., Keusters, Willem R., van Kalmthout, Ludwike W. M., Braat, Arthur J. A. T., de Keizer, Bart, Frederix, Geert W. J., Kooistra, Anko, Lavalaye, Jules, Lam, Marnix G. E. H., van Melick, Harm H. E.
Publicado 2022

Tolerability of concurrent external beam radiotherapy and [(177)Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

por van der Sar, Esmée C. A., Braat, Arthur J. A. T., van der Voort- van Zyp, Jochem R. N., van der Veen, Betty S., van Leeuwen, Pim J., de Vries-Huizing, Daphne M. V., Hendrikx, Jeroen M. A., Lam, Marnix G. E. H., Vogel, Wouter V.
Publicado 2023